Fredag 27 December | 15:44:53 Europe / Stockholm

Prenumeration

Kalender

Tid*
2026-02-26 08:00 Bokslutskommuniké 2025
2025-11-27 08:00 Kvartalsrapport 2025-Q3
2025-08-28 08:00 Kvartalsrapport 2025-Q2
2025-05-28 N/A Årsstämma
2025-05-28 08:00 Kvartalsrapport 2025-Q1
2025-02-27 08:00 Bokslutskommuniké 2024
2024-11-28 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-29 - Kvartalsrapport 2024-Q1
2024-05-27 - X-dag ordinarie utdelning SANION 0.00 SEK
2024-05-25 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2024-01-16 - Extra Bolagsstämma 2024
2023-11-30 - Kvartalsrapport 2023-Q3
2023-08-31 - Kvartalsrapport 2023-Q2
2023-05-25 - Årsstämma
2023-05-25 - Kvartalsrapport 2023-Q1
2023-05-24 - X-dag ordinarie utdelning SANION 0.00 SEK
2023-02-23 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-08-18 - Extra Bolagsstämma 2022
2022-05-27 - X-dag ordinarie utdelning SANION 0.00 SEK
2022-05-25 - Årsstämma
2022-05-25 - Kvartalsrapport 2022-Q1
2022-02-24 - Bokslutskommuniké 2021
2021-11-18 - Kvartalsrapport 2021-Q3
2021-09-16 - Extra Bolagsstämma 2021
2021-08-26 - Kvartalsrapport 2021-Q2
2021-05-27 - X-dag ordinarie utdelning SANION 0.00 SEK
2021-05-26 - Årsstämma
2021-05-26 - Kvartalsrapport 2021-Q1
2021-03-17 - Bokslutskommuniké 2020
2020-11-30 - Kvartalsrapport 2020-Q3
2020-10-23 - Extra Bolagsstämma 2020
2020-08-27 - Kvartalsrapport 2020-Q2
2020-05-28 - X-dag ordinarie utdelning SANION 0.00 SEK
2020-05-06 - Årsstämma
2020-05-06 - Kvartalsrapport 2020-Q1
2020-02-07 - Extra Bolagsstämma 2019
2020-02-07 - Bokslutskommuniké 2019
2019-11-13 - Kvartalsrapport 2019-Q3
2019-08-21 - Kvartalsrapport 2019-Q2
2019-05-31 - X-dag ordinarie utdelning SANION 0.00 SEK
2019-05-29 - Årsstämma
2019-05-29 - Kvartalsrapport 2019-Q1
2019-02-21 - Bokslutskommuniké 2018
2018-11-14 - Kvartalsrapport 2018-Q3
2018-08-22 - Kvartalsrapport 2018-Q2
2018-05-25 - X-dag ordinarie utdelning SANION 0.00 SEK
2018-05-24 - Årsstämma
2018-05-24 - Kvartalsrapport 2018-Q1
2018-02-21 - Bokslutskommuniké 2017
2018-01-19 - Extra Bolagsstämma 2018
2017-11-15 - Kvartalsrapport 2017-Q3
2017-08-23 - Kvartalsrapport 2017-Q2
2017-05-24 - X-dag ordinarie utdelning SANION 0.00 SEK
2017-05-23 - Årsstämma
2017-05-11 - Kvartalsrapport 2017-Q1
2017-02-21 - Bokslutskommuniké 2016
2016-10-13 - Extra Bolagsstämma 2016
2016-05-11 - X-dag ordinarie utdelning SANION 0.00 SEK
2016-05-10 - Årsstämma
2016-05-10 - Kvartalsrapport 2016-Q1
2016-02-19 - Bokslutskommuniké 2015
2015-11-20 - Kvartalsrapport 2015-Q3
2015-09-04 - Extra Bolagsstämma 2015
2015-08-31 - Kvartalsrapport 2015-Q2
2015-05-21 - X-dag ordinarie utdelning SANION 0.00 SEK
2015-05-20 - Årsstämma
2015-05-20 - Kvartalsrapport 2015-Q1
2015-02-20 - Bokslutskommuniké 2014
2014-11-21 - Kvartalsrapport 2014-Q3
2014-08-22 - Kvartalsrapport 2014-Q2

Beskrivning

LandDanmark
ListaSmall Cap Stockholm
SektorHälsovård
IndustriBioteknik
Saniona är verksamt inom bioteknik. Idag bedrivs forskning och utveckling av läkemedel för behandling av nervsjukdomar samt övriga autoimmuna sjukdomar. Läkemedelsportföljen är bred och innefattar läkemedel som för närvarande befinner sig i olika kliniska faser. En del av arbetet utförs även i samarbete med andra aktörer inom läkemedelsbranschen. Saniona har huvudkontor i Glostrup.
2024-02-15 16:00:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES PURSUANT TO APPLICABLE LAW. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.

The board of directors of Saniona AB ("Saniona" or the "Company") has today, based on the authorization granted by the extraordinary general meeting on 16 January 2024, resolved on a directed issue of 1,984,438 units to guarantors who have entered into guarantee commitments in the rights issue of units announced on 14 December 2023 (the "Rights Issue") and who have chosen to receive guarantee compensation in the form of newly issued units in Saniona (the "Compensation Issue"). The subscription price in the Compensation Issue amounts to SEK 4.23 per unit, corresponding to SEK 2.115 per share. The subscription price per unit corresponds to the volume-weighted average price of the Company's share on Nasdaq Stockholm during the subscription period in the Rights Issue, multiplied by two (2). The warrants are issued free of charge. One (1) unit consists of two (2) shares and one (1) warrant series TO 4. Payment is made by offsetting claims. The board of directors of Saniona has also, based on the authorization granted by the extraordinary general meeting on 16 January 2024, resolved to carry out a directed issue of convertibles (the "Convertibles") to Formue Nord Fokus A/S ("Formue Nord") for a total nominal amount of SEK 10 million (the "Convertible Issue"), in accordance with what was communicated in a press release on 14 December 2023. The consideration for the Convertible Issue is paid by offsetting the corresponding amount of the outstanding loan that the Company has previously obtained from Formue Nord and which was renegotiated in connection with the Rights Issue.

Terms for the Compensation Issue

In connection with the announcement of the Rights Issue, it was communicated that the Rights Issue was covered by guarantee commitments amounting to a total of approximately SEK 78.4 million. In accordance with the guarantee agreements, guarantee commitments entitled to guarantee compensation corresponding to eleven (11) per cent of the guaranteed amount in cash or fourteen (14) per cent of the guaranteed amount in units. In total, two guarantors have chosen to receive guarantee compensation in the form of newly issued units in accordance with the below.

Guarantor/subscriberNumber of subscribed unitsTotal subscription amount (SEK)
Fredrik Lundgren992,2194,197,086.81
Wilhelm Risberg992,2194,197,086.81
Total1,984,4388,394,173.62

Due to this, the board of directors of Saniona has today, based on the authorization granted by the extraordinary general meeting on 16 January 2024, resolved on the Compensation Issue, which comprises a total of 1,984,438 units, corresponding to approximately SEK 8.4 million. The cash component of the guarantee compensation amounts to approximately SEK 2.0 million.

Each unit consists of two (2) shares and one (1) warrant series TO 4. A total of 1,984,438 units are subscribed for, corresponding to 3,968,876 shares and 1,984,438 warrants series TO 4. The subscription price in the Compensation Issue amounts to SEK 4.23, which corresponds to a subscription price per share of SEK 2.115. The subscription price per unit corresponds to the volume-weighted average price of the Company's share on Nasdaq Stockholm during the subscription period in the Rights Issue, multiplied by two (2). The basis for calculating the subscription price was determined through negotiations between the guarantors and the Company, in consultation with financial advisors and through analysis of a number of market factors. In light of this, it is the board of directors’ assessment that the subscription price is at market. The warrants are issued free of charge.

The reasons for the deviation from the shareholders' preferential right are as follows. In accordance with the executed guarantee agreements, guarantee compensation shall be paid either in cash at an amount corresponding to eleven (11) per cent of the guaranteed amount or fourteen (14) per cent of the guaranteed amount in the form of newly issued units in the Company, in accordance with the terms and conditions stated above. As a result of the guarantee commitments, each subscriber thus has a claim on the Company regarding guarantee compensation. Each subscriber has declared its willingness to allow the Company to offset the debt regarding guarantee compensation by carrying out an offset issue. The Compensation Issue is thus carried out in order to fulfil the Company's obligations to the guarantors as a result of the guarantee agreements entered into. The Company's alternative to carrying out the Compensation Issue is to instead settle the guarantee compensation through cash payment. The board of directors is of the opinion that – taking into account current market conditions – it is in the interest of the Company’s financial position and in the interest of the shareholders to carry out the Compensation Issue on the stated terms and conditions, as the Company will then release funds that strengthen the Company's working capital.

Through the Compensation Issue, the number of shares in Saniona will increase by 3,968,876, from 107,269,376 to 111,238,252. The share capital will thereby increase by SEK 198,443.80, from SEK 5,363,468.80 to SEK 5,561,912.60. The Compensation Issue thus entails a dilution effect on the Company’s shares of approximately 3.6 per cent.

Through the Compensation Issue, 1,984,438 warrants series TO 4 are issued. In case all outstanding warrants series TO 4, including the warrants issued through the Rights Issue, are exercised for subscription of new shares in the Company, the number of shares will increase by an additional 45,126,836 shares to 156,365,088 shares, entailing an increased dilution of approximately 28.9 per cent, of which a maximum of approximately 1.8 per cent is attributable to the warrants issued through the Compensation Issue.

Each warrant series TO 4 entitles the holder to subscribe for one (1) new share in the Company at an exercise price corresponding to seventy (70) per cent of the volume-weighted average price of the Company's share on Nasdaq Stockholm during the period from and including 28 February 2025 up to and including 13 March 2025, however not less than the share's quota value. Subscription of shares by exercise of warrants series TO 4 takes place during the period from and including 18 March 2025 up to and including 1 April 2025. Upon full exercise of all warrants issued within the framework of the Compensation Issue, the Company will receive a maximum of approximately SEK 0.5 million before issue costs. Complete terms and conditions for warrants series TO 4 are available on the Company's website, www.saniona.com.

Terms for the Convertible Issue

In connection with the Rights Issue, the Company has renegotiated the outstanding loan from Formue Nord, which was originally obtained in July 2021, and which, after previous amortization/set-off, amounted to a total of approximately SEK 61.2 million. In connection with the Rights Issue, approximately SEK 1.6 million has been repaid by set-off and approximately SEK 18.4 million will be repaid in cash. Of the remaining loan of approximately SEK 41.2 million, approximately SEK 31.2 million will continue to run as a loan and SEK 10 million will be converted into Convertibles in the Company. The board of directors of the Company has therefore resolved, based on the authorization granted by the extraordinary general meeting held on 16 January 2024, on a directed issue of Convertibles to Formue Nord.

The total nominal amount of the Convertibles amounts to SEK 10 million. Formue Nord has the right to request conversion of the Convertibles into shares at a conversion price of SEK 3.09 per share, which corresponds to 150 per cent of the subscription price per share in the Rights Issue. Conversion may be requested as from the date of registration of the Convertibles with the Swedish Companies Registration Office up to and including 31 July 2025 and each request for conversion must relate to an amount of at least SEK 2 million. Payment for the Convertibles will be made by offsetting Formue Nord's claims under the existing outstanding loan.

The Convertibles carry an annual interest rate of STIBOR 3M plus an interest margin of 8.00 per cent, to be paid at the end of each calendar quarter. The Convertibles shall, if not previously converted, be repaid no later than 31 July 2025. The Company has the right to repay the Convertibles in advance at any time without additional costs, but if the Company requests to repay in advance, Formue Nord has the right to request conversion of the requested repayment amount instead.

The reasons for the deviation from the shareholders' preferential right is that the issue is made due to the restructuring of the loan agreement between the Company and Formue Nord that the parties agreed on in connection with the Rights Issue and which was announced on 14 December 2023. According to the new terms of the loan, approximately SEK 1.6 million has been repaid by set-off and approximately SEK 18.4 million will be repaid in cash. Of the remaining loan amount of approximately SEK 41.2 million, approximately SEK 31.2 million will continue to run as a loan and SEK 10 million will be converted into Convertibles in the Company. The board of directors has carefully considered various possibilities to finance the partial payment of the outstanding loan. In connection with this, the board of directors has, among other things, considered the possibility of financing the partial payment of SEK 10 million of the outstanding loan by increasing the size of the Rights Issue, but has made the assessment that such a rights issue would probably not be fully subscribed or subscribed to a sufficient extent. In an overall assessment of the possibility of financing the partial payment of SEK 10 million of the outstanding loan, the board of directors' overall assessment is thus that the reasons for carrying out a directed set-off issue of Convertibles outweigh the reasons that justify the main rule that new issues shall be carried out with preferential rights for the shareholders and a directed set-off issue of Convertibles is, in the opinion of the board of directors, the most advantageous alternative for the Company and the Company's shareholders.

The subscription price for the Convertibles and the other terms and conditions have been determined through negotiations with Formue Nord at arm’s length, in consultation with advisors and through analysis of several market factors, and is deemed by the board of directors to be in line with market conditions based on prevailing conditions on the capital market.

Advisers

Vator Securities AB is financial adviser and Setterwalls Advokatbyrå AB is legal adviser to the Company in connection with the Rights Issue. Vator Securities AB is also issuing agent in connection with the Rights Issue.